| Dr Jennifer L Edwards, DFNP, APRN, NP-BC | |
|
602 Sw 38th St, Lawton, OK 73505-6912 | |
| (580) 248-5780 | |
| Not Available |
| Full Name | Dr Jennifer L Edwards |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 602 Sw 38th St, Lawton, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063725547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 81703 (Oklahoma) | Primary |
| Entity Name | State Of Oklahoma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588755532 PECOS PAC ID: 4486558962 Enrollment ID: O20031125000846 |
News Archive
Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of the human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.
OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.
A selection of health policy stories from California, Missouri, Maine, Michigan, North Carolina, Texas and Georgia.
Medical researchers, politicians, and policymakers gathered at a Global Health Policy Summit in London Wednesday "to champion innovative solutions to the world's major health problems," Imperial College London reports in an article, which notes the summit, "the first event of its kind, is the result of a partnership between Imperial College London and the Qatar Foundation for education, science and community development" and "will tackle maternal health, primary care, non-infectious diseases and aging societies".
One of the characteristics of embryonic stem cells is their ability to form unusual tumors called teratomas. These tumors, which contain a mixture of cells from a variety of tissues and organs of the body, are typically benign. But they present a major obstacle to the development of human embryonic stem cell therapies that seek to treat a variety of human ailments such as Parkinson's, diabetes, genetic blood disorders and spinal cord injuries.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer L Edwards, DFNP, APRN, NP-BC 1207 Maple Ave, Elgin, OK 73538-9003 Ph: (580) 458-2373 | Dr Jennifer L Edwards, DFNP, APRN, NP-BC 602 Sw 38th St, Lawton, OK 73505-6912 Ph: (580) 248-5780 |
News Archive
Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of the human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.
OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.
A selection of health policy stories from California, Missouri, Maine, Michigan, North Carolina, Texas and Georgia.
Medical researchers, politicians, and policymakers gathered at a Global Health Policy Summit in London Wednesday "to champion innovative solutions to the world's major health problems," Imperial College London reports in an article, which notes the summit, "the first event of its kind, is the result of a partnership between Imperial College London and the Qatar Foundation for education, science and community development" and "will tackle maternal health, primary care, non-infectious diseases and aging societies".
One of the characteristics of embryonic stem cells is their ability to form unusual tumors called teratomas. These tumors, which contain a mixture of cells from a variety of tissues and organs of the body, are typically benign. But they present a major obstacle to the development of human embryonic stem cell therapies that seek to treat a variety of human ailments such as Parkinson's, diabetes, genetic blood disorders and spinal cord injuries.
› Verified 2 days ago
Jenny Rae Mohon, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1515 North East Lawrie Tatum Road, Usphs Lawton Indian Hospital, Lawton, OK 73507 Phone: 580-353-0350 | |
Sharon Nichelle Brown, AG-ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5508 Sw Tyler Ave, Lawton, OK 73505 Phone: 580-291-6280 | |
Katherine Nguyen, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6744 Nw Cache Rd, Lawton, OK 73505 Phone: 580-536-9355 | |
Dana Kaye Hulbert, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3811 W Gore Blvd, Ste 6, Lawton, OK 73505 Phone: 580-355-5242 Fax: 580-355-5245 | |
Mrs. Ellagene Elizabeth Cruz, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1602 Sw 82nd St, Lawton, OK 73505 Phone: 580-536-0077 | |
Theleka Williams, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6744 Nw Cache Rd, Lawton, OK 73505 Phone: 580-536-9355 Fax: 580-536-3537 |